l.vermeulen
TL2 Moderator · Kumasi
Contributes reviews on supplier material. Based in Kumasi.
Joined 19 November 2024 · last posted 1d · groups: translators
83 posts, newest first. Showing up to 150.
-
What a simple presence test is genuinely useful for Replied, post #3 · marked as the solution · Analytics › Home & field testing · 27 Jul 2026 · 16 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
-
Second pass at: When your prescriber and the evidence disagree Replied, post #54 · Clinical › Prescriber conversations · 22 Jul 2026 · 0 likes Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes, clarify whether your clinician considers this off-label use and…
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #42 · Research Methods › N-of-1 designs · 18 Jul 2026 · 3 likes Designing a personal experiment that could actually change your mind: that is the standard for an n-of-1 design. An experiment designed so that any result confirms what…
-
Revisiting: Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #5 · Compounds › Retatrutide · 16 Jul 2026 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Dose escalation in the published trials: the protocols started at lower doses and escalated by…
-
Private prescribing in the UK: what is actually involved Replied, post #62 · Regional › UK & Ireland · 11 Jul 2026 · 14 likes Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #41 · Analytics › Method validation · 9 Jul 2026 · 23 likes Coming back to post #39, because the follow-up matters more than the original answer. Linearity: the detector response is proportional to compound concentration across…
-
Designing a personal experiment that could change your mind — one year on Replied, post #72 · Research Methods › N-of-1 designs · 8 Jul 2026 · 7 likes Worth separating two things that post #68 runs together. Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach.…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #18 · Analytics › HPLC & UHPLC · 7 Jul 2026 · 4 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
How much context is too much context in a first post? Replied, post #17 · Start Here › How to Ask · 5 Jul 2026 · 26 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Follow-up: Reading an interaction checker output critically Replied, post #32 · Practice › Interactions · 5 Jul 2026 · 3 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Second pass at: Absence of evidence and evidence of absence Replied, post #32 · Research Methods › Statistics · 28 Jun 2026 · 0 likes Confounding: a third variable explains an apparent association. In randomised data, randomisation balances confounders. In observational data, confounders can be…
-
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #35 · Documentation › Doc review · 28 Jun 2026 · 6 likes Picking up post #32: that is the part I would want checked first. Promoted topic withdrawal: if a promoted topic becomes outdated or inaccurate and the maintainer does…
-
NHS criteria and how they are applied in practice Replied, post #12 · Regional › UK & Ireland · 26 Jun 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Aggregate verification data across the directory, with caveats Replied, post #12 · Sourcing › Independent verification · 25 Jun 2026 · 33 likes post #11 answers the question as asked. The question underneath it is different. Interpreting a result: a purity figure is one measurement on one vial on one day.…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #47 · Analytics › Impurities & related substances · 15 Jun 2026 · 6 likes post #46 is right about the mechanism and I think understates the practical bit. Dimer and higher-order multimers: two or more peptide molecules bonded together. They…
-
Batch numbers that do not match the vial label — what changed since Replied, post #34 · Sourcing › Red flags · 10 Jun 2026 · 16 likes Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming…
-
Request: a per-category review queue Replied, post #28 · Meta › Feature requests · 10 Jun 2026 · 5 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Why the cheapest option is often not the cheapest Replied, post #7 · Access › Pricing · 6 Jun 2026 · 16 likes I read post #5 twice before replying, because I had assumed the opposite. International pricing: the same compound costs very different amounts in different countries…
-
Prescription portability between countries Replied, post #55 · Access › International · 6 Jun 2026 · 0 likes Picking up post #52: that is the part I would want checked first. Insurance and coverage: coverage decisions are national. A compound approved in one country might not…
-
The anatomy of a question that gets answered within an hour Replied, post #67 · Start Here › How to Ask · 4 Jun 2026 · 0 likes On post #63 — agreed on the reasoning, with one qualification. Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which…
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #36 · Pharmacology › Pharmacokinetics · 2 Jun 2026 · 4 likes This follows post #33 rather than contradicting it. Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #2 · Outcomes › Body composition · 30 May 2026 · 4 likes Picking up the opening post: that is the part I would want checked first. Visceral fat: DXA does not distinguish visceral (organ-associated) fat from subcutaneous fat.…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #43 · Analytics › HPLC & UHPLC · 14 May 2026 · 5 likes post #42 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #76 · Evidence › Trials · 7 May 2026 · 0 likes Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a stand-in. HbA1c is a surrogate for long-term glucose control and the…
-
Tracking intake honestly when appetite is absent Replied, post #16 · Nutrition & Training › Protein & intake · 5 May 2026 · 25 likes Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly 2 to 3 grams per meal. That influences how much protein per meal matters, but…
-
Why retatrutide discussion here is more cautious than elsewhere Replied, post #8 · Compounds › Retatrutide · 24 Apr 2026 · 16 likes Picking up post #5: that is the part I would want checked first. Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is…
-
Clearance pathways and what renal impairment changes Replied, post #13 · Pharmacology › Pharmacokinetics · 18 Apr 2026 · 2 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
Fasting versus non-fasting and which tests care Replied, post #14 · Clinical › Bloodwork · 18 Apr 2026 · 1 like Coming back to post #12, because the follow-up matters more than the original answer. Liver enzymes: elevation does not specify cause. ALT and AST can rise from many…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #41 · Evidence › Journal club · 18 Apr 2026 · 14 likes Coming back to post #39, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #75 · Practice › Administration · 7 Apr 2026 · 0 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
-
Grapefruit: why this class is not the class that cares Replied, post #119 · Practice › Interactions · 4 Apr 2026 · 0 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #35 · Start Here › Welcome · 4 Apr 2026 · 3 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #9 · Data & Tools › Calculators · 1 Apr 2026 · 5 likes Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that says a certain dose is "compatible with" a certain…
-
Sample size intuition for a personal experiment — does this still hold? Replied, post #11 · Research Methods › Statistics · 28 Mar 2026 · 7 likes post #10 is right about the mechanism and I think understates the practical bit. Relative risk and odds ratios: both compare the rate in one group to the rate in…
-
Which fields on a certificate actually matter, ranked Replied, post #29 · Analytics › COA interpretation · 19 Mar 2026 · 25 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #68 · Practice › Interactions · 15 Mar 2026 · 0 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #43 · Evidence › Trials · 21 Feb 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Angle of injection and whether 90 degrees is always right Replied, post #97 · Practice › Administration · 9 Feb 2026 · 8 likes I read post #95 twice before replying, because I had assumed the opposite. Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #41 · Practice › Storage & stability · 27 Jan 2026 · 2 likes This follows post #38 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Research-use-only labelling: what it means and what it does not Replied, post #90 · Sourcing › Regulatory · 20 Jan 2026 · 0 likes On post #86 — agreed on the reasoning, with one qualification. Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #3 · Analytics › Mass spectrometry · 6 Jan 2026 · 15 likes post #2 answers the question as asked. The question underneath it is different. Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #34 · Regional › UK & Ireland · 3 Jan 2026 · 7 likes On post #30 — agreed on the reasoning, with one qualification. Regional variation in NHS: access varies dramatically by region depending on local commissioning…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #99 · Practice › Side effects · 29 Dec 2025 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
The decimal-point error, and the habit that catches it Replied, post #93 · Practice › Reconstitution · 17 Dec 2025 · 21 likes Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually resolve with gentle warming and time. Persistent…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #44 · Sourcing › Vendor reports · 10 Dec 2025 · 16 likes Disputed records: when a result disagreed and was not explained, the record says disputed and stays that way. We do not remove inconvenient history; we document it.
-
Robustness: the parameters worth deliberately varying Replied, post #38 · Analytics › Method validation · 3 Dec 2025 · 1 like Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background. LOQ is the lowest concentration at which the method meets…
-
A history of disordered eating: proceeding carefully Replied, post #18 · Wellbeing › Mental health · 2 Dec 2025 · 10 likes Coming back to post #16, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Managing an unplanned gap in supply — what changed since Replied, post #122 · Access › Shortages · 21 Nov 2025 · 22 likes post #121 answers the question as asked. The question underneath it is different. Compounding during shortages: some jurisdictions allow pharmacy compounding when a…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Started this topic · Analytics › Impurities & related substances · 11 Nov 2025 · 0 likes Posting this under the heading it deserves: Revisiting: Aggregates and why a purity assay may miss them entirely Everything below is what sits behind that. I would like…
-
New subcategory: rationale and scope Replied, post #138 · Meta › Announcements · 27 Oct 2025 · 10 likes Worth separating two things that post #134 runs together. Staff-only posts: some announcements are visible only to staff (concerning internal operations). Members see…
-
Payment mechanics and the recovery options that do not exist Replied, post #64 · Sourcing › Payments · 21 Oct 2025 · 30 likes Recurring billing: if a supplier sets up recurring billing by default, understanding the terms for cancellation is important before the first charge.
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #5 · Start Here › Welcome · 20 Oct 2025 · 5 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #46 · Compounds › Cagrilintide & amylin analogues · 3 Oct 2025 · 3 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #24 · Clinical › Special populations · 19 Sep 2025 · 0 likes post #23 is right about the mechanism and I think understates the practical bit. Renal impairment: the compounds are cleared renally to some degree. Dose adjustments…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #9 · Compounds › Tirzepatide · 19 Sep 2025 · 23 likes Coming back to post #7, because the follow-up matters more than the original answer. Nausea profile: some people report tirzepatide as less nausea-prone than…
-
The "under review" status pill and when a moderator applies it — a second dataset Started this topic · Evidence › Preprints · 8 Aug 2025 · 56 likes The "under review" status pill and when a moderator applies it — a second dataset Writing it up because I had to work it out twice and would rather nobody else did. I…
-
What a documentation review can and cannot tell you Replied, post #45 · Sourcing › Independent verification · 23 Jul 2025 · 16 likes post #44 answers the question as asked. The question underneath it is different. Interpreting a result: a purity figure is one measurement on one vial on one day.…
-
Trial registration and comparing the protocol with the paper Replied, post #22 · Evidence › Trials · 17 Jul 2025 · 0 likes Picking up post #19: that is the part I would want checked first. Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #165 · Practice › Reconstitution · 15 Jul 2025 · 7 likes On post #161 — agreed on the reasoning, with one qualification. Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100…
-
Tracking that stops updating and then resumes Replied, post #7 · Sourcing › Logistics · 1 Jul 2025 · 19 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #131 · Access › Insurance & coverage · 15 Jun 2025 · 7 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
-
Washout: how long is long enough, and for what purpose Replied, post #31 · Pharmacology › Pharmacokinetics · 31 May 2025 · 12 likes post #30 is right about the mechanism and I think understates the practical bit. Renal clearance: these compounds are cleared partly via the kidney. In severe renal…
-
Pre-registering a personal experiment, seriously Replied, post #48 · Research Methods › N-of-1 designs · 29 May 2025 · 29 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Asking about a compound your prescriber has not heard of Replied, post #51 · Clinical › Prescriber conversations · 29 May 2025 · 27 likes Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring plan. Asking "can we start lower" or "can we escalate…
-
Coming back to: When "no data" is the complete and final answer Started this topic · Compounds › Other compounds · 27 May 2025 · 8 likes When "no data" is the complete and final answer I have a specific reason for asking rather than idle curiosity, and the context is below. I have seen SURPASS-4 ( Lancet…
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #52 · Compounds › Retatrutide · 26 May 2025 · 21 likes Dose escalation in the published trials: the protocols started at lower doses and escalated by defined steps. The step sizes are documented and they may or may not…
-
Coming back to: Getting a referral rather than a refusal Replied, post #4 · Clinical › Prescriber conversations · 26 May 2025 · 25 likes Discussing off-label dosing: if you want to dose differently than the label specifies (slower titration, higher final dose), discussing that explicitly and…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #80 · Compounds › Tirzepatide · 9 May 2025 · 0 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #19 · Compounds › Oral incretins · 17 Apr 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #100 · Access › International · 15 Mar 2025 · 4 likes Compounding in different countries: some countries allow pharmacy compounding under defined conditions; others do not. The rules are jurisdiction-specific and change.
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #51 · Pharmacology › Receptor biology · 6 Mar 2025 · 0 likes Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and peripheral effects (gastric motility, insulin). The…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #22 · Analytics › COA interpretation · 23 Feb 2025 · 9 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #44 · Compounds › Secretagogues & GH axis · 22 Jan 2025 · 16 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
-
Fixed versus detachable needles: the trade-offs Replied, post #118 · Devices › Syringes & needles · 17 Jan 2025 · 22 likes On post #114 — agreed on the reasoning, with one qualification. Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #10 · Compounds › Other compounds · 5 Jan 2025 · 24 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
-
A supplier that answers analytical questions with restated claims Replied, post #3 · Sourcing › Red flags · 26 Dec 2024 · 1 like post #2 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Promotion criteria, and the one that stops most nominations Replied, post #121 · Documentation › Doc review · 23 Nov 2024 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Food noise reducing and the disorientation that can follow Replied, post #44 · Wellbeing › Mental health · 20 Nov 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
About the International category Replied, post #8 · Access › International · 9 Oct 2024 · 0 likes Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago.
-
Correlation in a self-tracked dataset: what it can support Replied, post #161 · Research Methods › Statistics · 26 Aug 2024 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #49 · Analytics › Mass spectrometry · 20 Aug 2024 · 15 likes Resolution: "high resolution" commonly means
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #74 · Evidence › Journal club · 28 Jul 2024 · 15 likes Picking up post #71: that is the part I would want checked first. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular…
-
Coming back to: Pricing far outside the range, in either direction Replied, post #4 · Sourcing › Red flags · 19 Jul 2024 · 13 likes Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get a clear answer, that is a red flag. Traceability is not…